Orthobiologics

MiMedx Planning U.S. Launch for Ambient Temperature Version of OrthoFlo

by on July 25, 2016

MiMedx is planning a U.S. launch for a next-generation lyophilized (freeze-dried) version of OrthoFlo, its amniotic fluid-based allograft for use in in orthopaedic and sports-medicine applications.

This anticipated version of OrthoFlo can be stored at ambient temperature and has a...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

Subscribe Nowdocument icon

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

RELATED ARTICLES
Biocomposites Nanobone
Biocomposites to Distribute NanoBone in the UK
Medacta M-ARS ACL Technique
Medacta Launches a Simplified Approach for the M-ARS ACL Technique
Catalyst OrthoScience Total Shoulder
Catalyst OrthoScience Surpasses 10,000 Total Shoulder Arthroplasty Procedures
Paragon 28 APEX 3D Right Angle Drill
Paragon 28 Launches New Drill for APEX 3D Total Ankle Replacement
Treatment Opens in Spinal Fusion Trial with Theradaptive OsteoAdapt SP


Contact Us

0